Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
17.93
+0.32 (1.82%)
At close: Jul 2, 2026, 4:00 PM EDT
17.78
-0.15 (-0.84%)
After-hours: Jul 2, 2026, 5:14 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $2.55 billion as of July 2, 2026. Its market cap has increased by 249.12% in one year.
Market Cap
2.55B
Enterprise Value
2.37B
1-Year Change
249.12%
Ranking
Category
Stock Price
$17.93
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $2.55B, an increase of 2,895.32%. That is a compound annual growth rate of 60.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 2.55B | 58.57% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 2.75B |
| Immunome | 2.67B |
| Nurix Therapeutics | 2.48B |
| AbCellera Biologics | 2.48B |
| Intellia Therapeutics | 2.45B |
| Mineralys Therapeutics | 2.44B |
| Kodiak Sciences | 2.41B |
| Biohaven | 2.40B |